- $15.65bn
- $15.12bn
- $1.08bn
- 74
- 12
- 87
- 58
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 302 | 391 | 625 | 820 | 1,083 |
Cost of Revenue | |||||
Gross Profit | 127 | 187 | 307 | 364 | 493 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 419 | 613 | 1,094 | 1,361 | 1,529 |
Operating Profit | -116 | -222 | -468 | -541 | -446 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -123 | -230 | -471 | -547 | -435 |
Provision for Income Taxes | |||||
Net Income After Taxes | -125 | -230 | -472 | -548 | -435 |
Net Income Before Extraordinary Items | |||||
Net Income | -125 | -230 | -472 | -548 | -435 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -125 | -230 | -472 | -548 | -435 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.91 | -2.79 | -5.21 | -5.57 | -3.78 |